Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
PDL BioPharma's peak revenue was $590.4M in 2015. The peak quarterly revenue was $178.1M in 2015(q4).
PDL BioPharma's revenue increased from $63.1m in 2000 to $30.7M currently. That's a -51.3% change in annual revenue.
| Fiscal year / year | PDL BioPharma revenue |
|---|---|
| 2009 | $318.2M |
| 2010 | $345.0M |
| 2011 | $362.0M |
| 2012 | $380.9M |
| 2013 | $456.3M |
| 2014 | $581.2M |
| 2015 | $590.4M |
| 2016 | $244.3M |
| 2017 | $320.1M |
| 2018 | $32.0M |
| 2019 | $30.7M |
Rate PDL BioPharma's financial transparency
PDL BioPharma saw the greatest revenue growth in 2005, when revenue increased by 65.02%.
PDL BioPharma had the lowest revenue growth in 2018, when revenue changed by -89.99%.
| Year | PDL BioPharma growth |
|---|---|
| 2009 | 8%↑ |
| 2010 | 8%↑ |
| 2011 | 5%↑ |
| 2012 | 5%↑ |
| 2013 | 20%↑ |
| 2014 | 27%↑ |
| 2015 | 2%↑ |
| 2016 | -59%↓ |
| 2017 | 31%↑ |
| 2018 | -90%↓ |
| 2019 | -4%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $62.6M | $125.9M | $71.4M | $58.3M |
| 2010 | $62.1M | $120.3M | $86.4M | $76.1M |
| 2011 | $83.3M | $122.1M | $83.8M | $72.8M |
| 2012 | $77.3M | $125.9M | $85.2M | $92.4M |
| 2013 | $91.8M | $148.5M | $100.2M | $112.0M |
| 2014 | $136.8M | $162.8M | $164.6M | $117.1M |
| 2015 | $149.7M | $138.1M | $124.6M | $178.1M |
| 2016 | $103.1M | $21.0M | $53.6M | $66.5M |
| 2017 | $45.4M | $143.8M | $62.7M | $68.0M |
| 2018 | $38.5M | $46.6M | $67.9M | ($121.0M) |
| 2019 | $38.9M | ($22.5M) | $8.0M | $8.5M |
| 2020 | $6.0M | $5.2M | - | - |
Do you work at PDL BioPharma?
Is PDL BioPharma transparent about its revenue structure?
| CEO | Christopher Stone |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 75 |
| Date Founded | 1986 |
| Headquarters | Incline Village, Nevada |
| Number of Locations | 1 |
| Revenue | $30.7M |
| Net Income | -$70,411,000 |
| Gross Proft | $12.1M (2019) |
| PE Ratio | -6.59 |
| Tax Rate | 0.1% |
| Market Capitalization | $464.2M |
| Total Assets | $717,206,000 |
| Ticker | PDLI |
PDL BioPharma's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
PDL BioPharma's smallest competitor is Sequoia Consulting Group, Llc with revenue of $1.3M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Amgen | $93,349 | $33.4B | 22,000 | 604 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 647 |
| Sarepta Therapeutics | $94,985 | $1.9B | 840 | 28 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Nektar Therapeutics | $83,561 | $98.4M | 718 | - |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 199 |
| Merck | $90,328 | $64.2B | 74,000 | 1,527 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,715 |
| Allergan plc | $99,508 | $7.2B | 11,400 | 28 |
| Esperion Therapeutics | $75,747 | $332.3M | 218 | 28 |
Zippia gives an in-depth look into the details of PDL BioPharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about PDL BioPharma. The employee data is based on information from people who have self-reported their past or current employments at PDL BioPharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by PDL BioPharma. The data presented on this page does not represent the view of PDL BioPharma and its employees or that of Zippia.
PDL BioPharma may also be known as or be related to PDL BIOPHARMA INC., PDL BioPharma, PDL BioPharma Inc, PDL BioPharma Inc., PDL BioPharma, Inc. and PDL Biopharma.